Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by cash on hand, at SGD 28.1M, followed by Oruka Therapeutics (SGD 60.6M) and Dianthus Therapeutics (SGD 65.9M). Figures as of 19 Nov 2026, 03:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSGD 28.1M
- Median
- SGD 739.7M
- Combined market value
- SGD 6.53T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SGD 28.1M | SGD 6.8B | SGD 161.11 | 0.62% down | 233% up | ||
| 2 | Oruka TherapeuticsORKA · Health Care | SGD 60.6M | SGD 8.4B | SGD 123.54 | 0.60% down | 241% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | SGD 65.9M | SGD 6.1B | SGD 108.36 | 3.45% down | 113% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 70.1M | SGD 10.6B | SGD 153.60 | 2.08% up | 13% up | ||
| 5 | Edgewise TherapeuticsEWTX · Health Care | SGD 78.9M | SGD 5.8B | SGD 53.38 | 1.59% down | 88% up | ||
| 6 | ErascaERAS · Health Care | SGD 95.2M | SGD 6.2B | SGD 17.75 | 0.94% down | 403% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | SGD 102.1M | SGD 12.9B | SGD 85.32 | 5.44% up | 107% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | SGD 110.6M | SGD 12.4B | SGD 130.92 | 8.15% up | 286% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | SGD 120M | SGD 6.2B | SGD 64.83 | 1.68% down | 44% up | ||
| 10 | Corcept TherapeuticsCORT · Health Care | SGD 155.5M | SGD 9.6B | SGD 87.47 | 3.25% down | 8% down | ||
| 11 | CytokineticsCYTK · Health Care | SGD 158.1M | SGD 9.2B | SGD 66.22 | 0.64% down | 20% down | ||
| 12 | Protagonist TherapeuticsPTGX · Health Care | SGD 165.7M | SGD 10.7B | SGD 164.08 | 2.00% up | 46% up | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 211M | SGD 16.1B | SGD 19.33 | 1.28% up | 5% up | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 213.7M | SGD 9.6B | SGD 122.65 | 0.06% down | 126% up | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | SGD 225.7M | SGD 7.7B | SGD 385.43 | 1.67% up | 43% up | ||
| 16 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 256.4M | SGD 11.9B | SGD 513.65 | 5.67% down | 24% down | ||
| 17 | Summit TherapeuticsSMMT · Health Care | SGD 290.7M | SGD 10.8B | SGD 13.55 | 1.59% down | 36% down | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 292.3M | SGD 7.9B | SGD 55.63 | 0.28% up | 10% up | ||
| 19 | Definium TherapeuticsDFTX · Health Care | SGD 332.7M | SGD 5.1B | SGD 37.57 | 0.88% down | 169% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | SGD 363.9M | SGD 9.8B | SGD 28.23 | 3.60% up | 83% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | SGD 382.8M | SGD 7.8B | SGD 119.34 | 0.59% up | 31% up | ||
| 22 | Cogent BiosciencesCOGT · Health Care | SGD 402.6M | SGD 6.2B | SGD 35.88 | 0.14% down | 20% down | ||
| 23 | Axsome TherapeuticsAXSM · Health Care | SGD 416.7M | SGD 9.1B | SGD 172.90 | 1.43% down | 7% down | ||
| 24 | Belite BioBLTE · Health Care | SGD 455.4M | SGD 8.2B | SGD 201.59 | 0.94% down | 31% up | ||
| 25 | Praxis Precision MedicinesPRAX · Health Care | SGD 461.1M | SGD 11B | SGD 393.80 | 0.04% up | 61% up | ||
| 26 | Ionis PharmaceuticalsIONS · Health Care | SGD 480.3M | SGD 5.9B | SGD 35.34 | 1.59% up | 64% down | ||
| 27 | AlkermesALKS · Health Care | SGD 501.4M | SGD 10.2B | SGD 60.45 | 3.08% up | 58% up | ||
| 28 | InsmedINSM · Health Care | SGD 658.6M | SGD 33.9B | SGD 154.58 | 1.69% down | 40% down | ||
| 29 | Elanco Animal HealthELAN · Health Care | SGD 703.2M | SGD 17.2B | SGD 34.45 | 3.29% up | 20% up | ||
| 30 | BridgeBio PharmaBBIO · Health Care | SGD 735.6M | SGD 19.6B | SGD 100.66 | 1.58% up | 17% up | ||
| 31 | ABIVAXABVX · Health Care | SGD 739.7M | SGD 9.5B | SGD 108.17 | 2.11% up | 27% down | ||
| 32 | Royalty PharmaRPRX · Health Care | SGD 798.3M | SGD 50.9B | SGD 88.61 | 0.01% down | 78% up | ||
| 33 | Ascendis PharmaASND · Health Care | SGD 881.9M | SGD 22.9B | SGD 348.81 | 0.32% down | 28% up | ||
| 34 | Legend BiotechLEGN · Health Care | SGD 1.2B | SGD 4.1B | SGD 20.97 | 0.87% up | 42% down | ||
| 35 | GrifolsGRFS · Health Care | SGD 1.2B | SGD 7.4B | SGD 10.93 | 1.85% down | 1% up | ||
| 36 | PTC TherapeuticsPTCT · Health Care | SGD 1.3B | SGD 6.5B | SGD 77.72 | 0.22% down | 20% down | ||
| 37 | PfizerPFE · Health Care | SGD 1.5B | SGD 206.4B | SGD 36.21 | 1.44% down | 14% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.7B | SGD 15.4B | SGD 79.26 | 4.99% up | 11% up | ||
| 39 | ViatrisVTRS · Health Care | SGD 1.7B | SGD 30B | SGD 26.17 | 0.83% down | 96% up | ||
| 40 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 1.8B | SGD 20.5B | SGD 319.71 | 2.93% up | 37% up | ||
| 41 | Roivant SciencesROIV · Health Care | SGD 1.8B | SGD 36.2B | SGD 49.97 | 0.05% up | 90% up | ||
| 42 | United TherapeuticsUTHR · Health Care | SGD 2B | SGD 31.7B | SGD 744.96 | 1.16% down | 23% up | ||
| 43 | Alnylam PharmaceuticalsALNY · Health Care | SGD 2.1B | SGD 25.8B | SGD 192.78 | 4.54% down | 66% down | ||
| 44 | GenmabGMAB · Health Care | SGD 2.2B | SGD 40.6B | SGD 65.77 | 1.91% down | 70% up | ||
| 45 | ZoetisZTS · Health Care | SGD 3B | SGD 44.9B | SGD 110.41 | 2.50% up | 29% down | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | SGD 4B | SGD 126.2B | SGD 1,220.05 | 1.28% down | 36% up | ||
| 47 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 4.6B | SGD 63.6B | SGD 54.49 | 0.92% down | 74% up | ||
| 48 | Takeda PharmaceuticalTAK · Health Care | SGD 4.8B | SGD 87.7B | SGD 27.45 | 1.71% down | 54% up | ||
| 49 | Novo NordiskNVO · Health Care | SGD 5.1B | SGD 224.2B | SGD 50.88 | 3.12% down | 17% down | ||
| 50 | GSKGSK · Health Care | SGD 5.8B | SGD 125.6B | SGD 62.68 | 1.34% down | 6% up | ||
| 51 | BeOne MedicinesONC · Health Care | SGD 5.9B | SGD 59.5B | SGD 520.78 | 2.34% down | 17% up | ||
| 52 | Vertex PharmaceuticalsVRTX · Health Care | SGD 6.6B | SGD 175.5B | SGD 692.20 | 0.42% up | 27% up | ||
| 53 | AbbVieABBV · Health Care | SGD 6.7B | SGD 652.3B | SGD 369.05 | 2.33% down | 26% up | ||
| 54 | AstraZenecaAZN · Health Care | SGD 7.4B | SGD 357.7B | SGD 230.66 | 1.93% down | 2% up | ||
| 55 | Eli LillyLLY · Health Care | SGD 9.4B | SGD 1.59T | SGD 1,784.20 | 2.32% down | 35% up | ||
| 56 | SanofiSNY · Health Care | SGD 11B | SGD 146B | SGD 60.80 | 0.86% down | 4% down | ||
| 57 | Abbott LaboratoriesABT · Health Care | SGD 11B | SGD 233.5B | SGD 134.81 | 0.22% down | 17% down | ||
| 58 | Bristol-Myers SquibbBMY · Health Care | SGD 13.2B | SGD 157.1B | SGD 76.85 | 2.92% down | 34% up | ||
| 59 | NovartisNVS · Health Care | SGD 14.8B | SGD 378.2B | SGD 200.27 | 2.46% down | 25% up | ||
| 60 | Merck & CoMRK · Health Care | SGD 18.8B | SGD 438.3B | SGD 177.78 | 3.90% down | 51% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | SGD 25.4B | SGD 847.1B | SGD 351.87 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2903 SGD).
Questions and answers
Which pharmaceutical companies have the lowest cash on hand?
Veradermics (SGD 28.1M), Oruka Therapeutics (SGD 60.6M) and Dianthus Therapeutics (SGD 65.9M) have the lowest cash on hand of the 61 pharmaceutical companies ranked here as of 19 Nov 2026, 03:16 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of SGD 6.53T as of 19 Nov 2026, 03:16 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.